Navigation Links
Gloucester Pharmaceuticals Reports on Romidepsin and Erlotinib,Combination in Non-Small Cell Lung Cancer Presented at American,Association of Cancer Research Annual Meeting

imately 75-80% of NSCLCs," commented Jean Nichols, Ph.D., Executive Vice-President and Chief Scientific Officer at Gloucester.

"The preclinical synergy seen in this study provides a strong rationale for conducting clinical studies of the combination. If similar results are seen clinically, the potential exists to substantially increase the use of TKIs such as erlotinib in a broader population of lung cancer," she concluded.

About Non-Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths worldwide. There are over 1.2 million cases of lung cancers every year in the world, and 1.1 million people will die from their disease. Non-small cell lung cancer accounts for approximately 80% of lung cancer.

About Romidepsin

Romidepsin is a novel agent in a new class of anti-cancer drugs known as histone deacetylase inhibitors. The Company is conducting a pivotal phase II study of romidepsin for patients with cutaneous T-cell lymphoma (CTCL) and has initiated a pivotal phase II study for patients with peripheral T-cell lymphoma (PTCL). Romidepsin has received Orphan Drug Designation from the Food and Drug Administration (FDA) for the treatment of non-Hodgkin T-cell lymphomas, which includes CTCL and PTCL. In addition, the European Agency for the Evaluation of Medicinal Products (EMEA) has issued Orphan Drug status for the treatment of both CTCL and PTCL. Fast Track status for CTCL has also been designated by the FDA. Romidepsin is in clinical trials for a variety of other hematological malignancies and solid tumors, including hormone refractory prostate cancer, pancreatic cancer and multiple myeloma. These trials and others are being conducted by the Company or the National Cancer Institute (NCI) under a Cooperative Research and Development Agreement (CRADA) with the Company.

About Gloucester Pharmaceuticals, Inc.

Gloucester Pharmaceuticals, Inc. is a privately-held, venture-backed company that develops an
'"/>




Page: 1 2 3

Related medicine technology :

1. Gloucester Pharmaceuticals Reports Positive Interim Phase II Data on Romidepsin for T-Cell Lymphomas at the 2007 American Society of Clinical Oncology Annual Meeting
2. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
3. Gloucester Pharmaceuticals Announces Multiple Presentations of Preclinical Romidepsin Data at American Association of Cancer Research Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:6/2/2015)... 2, 2015 The Canadian Society for Vascular Surgery ... treatments or procedures that are commonly ordered but ... of Choosing Wisely Canada.  The list identifies five ... between patients and physicians about what care is ... Vascular Surgery,s list identified the following five (5) ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/sn8mlw/picture_archiving ) has announced the ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... the period 2014 through 2020. Also, a seven-year historic analysis ...
(Date:6/2/2015)... 2015 Intarcia Therapeutics, Inc. today ... its recently announced synthetic royalty / equity convert financing, ... have purchased Convertible Limited Recourse Notes from Intarcia and ... of any future global net sales of ITCA 650 ... also have the option, commencing upon U.S. regulatory approval ...
Breaking Medicine Technology:As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
... AMSTERDAM, July 12, 2011 , - Helping ... a Fast -moving , Field ... of Current Opinion,in Virology - a new journal in ... Opinion in,Virology was launched to provide a systematic, comprehensive,and filtered ...
... CONGERS, N.Y., July 12, 2011 Chartwell Pharmaceuticals announced ... registered pharmaceutical manufacturer with the Federal Drug Administration agency. ... for the company, which is in the process of ... pharmaceuticals market. Chartwell,s Senior Director of ...
Cached Medicine Technology:Elsevier Launches Current Opinion in Virology 2
(Date:6/2/2015)... 02, 2015 CRN International has been named ... to Employment , a Connecticut state program that takes active ... place them at appropriate companies. , Platform to Employment is ... the Connecticut Department of Labor. CRN, a 40-year-old radio marketing ... program, is being recognized for its “hard work and dedication.” ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 ... has joined the firm in a newly created position ... accounts and support organizations committed to improving employee retention ... a wealth of marketing experience and most recently worked ... up that was recently taken over a global mobile ...
(Date:6/2/2015)... Camarillo, Calif. (PRWEB) June 02, 2015 ... designing and manufacturing high performance connector solutions and ... MINI-SNAP® advanced connector solutions to the US market. ... connector with Push-Pull locking capabilities. The self- securing ... range of demanding applications that require significant customization ...
(Date:6/2/2015)... 02, 2015 Residents of Monarch Landing ... swim, take a fitness class, do yoga, play volleyball, ... In preparation for the Alzheimer’s Association’s Walk to End ... will take part in a challenge to exercise for ... Landing’s management company. , While the walk will raise ...
(Date:6/2/2015)... The Radiosurgery Society® (RSS), a ... RSSearch® Patient Registry evaluating the treatment patterns and ... the treatment of centrally located primary non-small cell ... The study, published in the May, 2015, issue ... patients with 114 centrally located lung tumors who ...
Breaking Medicine News(10 mins):Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Insightlink Communications Appoints New Director of Marketing and Client Engagement 2Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3
... as salmonella outbreak action continues; Girl Scouts, Hershey and Kraft ... (HealthDay News) -- Another person has died from salmonella poisoning ... nationwide number to seven. , According to a reports in ... the death of an elderly Minnesota woman Jan. 23 was ...
... transcription school, provides students with access to ... KB. Developed by experts at ... and transcription industry technology veterans at InterFix, ... of online medical transcription reference materials into ...
... a less invasive alternative to hysterectomy, researchers note ... fewer women than previously thought need additional surgery ... undergoing an alternative to hysterectomy called global endometrial ... a relatively new procedure, has been regarded as ...
... 23 The decision by President Barack Obama ... disappointing," said Cardinal Justin Rigali, chairman of the ... statement January 23, after President Obama issued the ... perform and promote abortion in developing nations. Cardinal ...
... Jan. 23 The following statement of Reverend Dr. ... Coalition for Reproductive Choice was released today:After eight years ... women and children worldwide, President Obama has put the ... and compassion by overturning the Bush administration,s global gag ...
... Jan. 23 Jon O,Brien, president of Catholics for ... the Global Gag Rule by President Barack Obama."Today,s executive ... Rule as it is more commonly known, is tremendously ... journey towards restoring confidence in America and America,s foreign ...
Cached Medicine News:Health News:Seventh Salmonella Death Tied to Peanut Products 2Health News:Seventh Salmonella Death Tied to Peanut Products 3Health News:Career Step, Leading School In Growing Health Documentation Industry, Adds Online Reference Tool 2Health News:Career Step, Leading School In Growing Health Documentation Industry, Adds Online Reference Tool 3Health News:Menstrual Bleeding Treatment Safer Than Thought 2Health News:After Eight Years of Injustice, International Family Planning Funding is Restored 2Health News:Catholics for Choice Statement on Overturning the Mexico City Policy 2
... Finntip Filters are ideal ... amplification methods, or for ... contamination might occur. They ... DNA/RNA solutions, infectious materials, ...
1000 L, Racked, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes....
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
Medicine Products: